Invesco’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$403K Sell
86,194
-940,644
-92% -$4.39M ﹤0.01% 3260
2025
Q1
$5.64M Buy
1,026,838
+957,822
+1,388% +$5.26M ﹤0.01% 2084
2024
Q4
$234K Buy
69,016
+1,350
+2% +$4.58K ﹤0.01% 3471
2024
Q3
$193K Buy
67,666
+1,137
+2% +$3.24K ﹤0.01% 3511
2024
Q2
$150K Buy
66,529
+2,727
+4% +$6.14K ﹤0.01% 3685
2024
Q1
$141K Buy
63,802
+625
+1% +$1.38K ﹤0.01% 3694
2023
Q4
$148K Sell
63,177
-256,471
-80% -$603K ﹤0.01% 3610
2023
Q3
$595K Sell
319,648
-1,784,974
-85% -$3.32M ﹤0.01% 3107
2023
Q2
$5.51M Buy
2,104,622
+2,285
+0.1% +$5.99K ﹤0.01% 2179
2023
Q1
$3.43M Buy
2,102,337
+2,276
+0.1% +$3.71K ﹤0.01% 2397
2022
Q4
$2.79M Sell
2,100,061
-6,994
-0.3% -$9.3K ﹤0.01% 2502
2022
Q3
$3.29M Buy
2,107,055
+6,849
+0.3% +$10.7K ﹤0.01% 2418
2022
Q2
$3.23M Buy
2,100,206
+62,816
+3% +$96.7K ﹤0.01% 2486
2022
Q1
$5.22M Buy
2,037,390
+1,264
+0.1% +$3.24K ﹤0.01% 2345
2021
Q4
$5.97M Sell
2,036,126
-688
-0% -$2.02K ﹤0.01% 2305
2021
Q3
$4.99M Sell
2,036,814
-488
-0% -$1.2K ﹤0.01% 2381
2021
Q2
$8.29M Sell
2,037,302
-7,718
-0.4% -$31.4K ﹤0.01% 2169
2021
Q1
$9.22M Buy
2,045,020
+1,969
+0.1% +$8.88K ﹤0.01% 1994
2020
Q4
$10.1M Buy
2,043,051
+41,063
+2% +$202K ﹤0.01% 1807
2020
Q3
$11.9M Buy
2,001,988
+105
+0% +$623 ﹤0.01% 1571
2020
Q2
$5.33M Buy
2,001,883
+1,000,000
+100% +$2.66M ﹤0.01% 1956
2020
Q1
$1.95M Buy
1,001,883
+1,883
+0.2% +$3.67K ﹤0.01% 2401
2019
Q4
$7.05M Hold
1,000,000
﹤0.01% 1952
2019
Q3
$9.83M Hold
1,000,000
﹤0.01% 1749
2019
Q2
$11.4M Buy
+1,000,000
New +$11.4M ﹤0.01% 1693